Article
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy
30 Oct 2019
Abstract excerpt
C.A.B. has received material support from Myriad Neuroscience, CNSDose, Genomind, and AB-Biotics and has ongoing research collaborations with CNSDose and MyDNA but does not have equity, stocks, or options in these companies or any other pharmacogenetic companies. S.A.S. is a paid employee of Sema4. J.K.H. is a paid consultant for Quest Diagnostics and 23andMe. All other authors declared no competing interests for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
